Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-25 @ 2:41 AM
NCT ID:
NCT01347333
Eligibility Criteria:
Inclusion Criteria:
* Patient age \>= 18 years
* Zubrod performance status of 0-3
* Oligometastases (1-3) with aggregate tumor diameter \< 6 cm
* Metastases from neuroendocrine tumors with functional endocrine syndromes for symptom palliation
* Unresectable hepatocellular carcinoma (HCC)
* Unresectable intrahepatic cholangiocarcinoma (IHCC)
* Maximum tumor diameter \< 6 cm
* Adequate liver function:
Total bilirubin \< 3 mg/dL Serum albumin \> 2.5 g/dL Serum levels of liver enzymes \< 3 times the upper limit of normal Normal PT and PTT unless patient is receiving anticoagulant medication
\- Signed study-specific consent form
Exclusion Criteria:
* Maximum tumor diameter \> 6 cm
* Prior radiotherapy to the liver
* Pregnant or lactating women, due to potential exposure of the fetus to RT and unknown effects of RT on lactating females
* Patients with psychiatric or addictive disorder that would preclude obtaining informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01347333
Study Brief:
Protocol Section:
NCT01347333